Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Leukemia

Showing results (1481-1490 of 9,628) with videos related to

Pageof 963
Sort By:
Leukemia|December 10, 2020
Targeted inhibition of cooperative mutation- and therapy-induced AKT activation in AML effectively enhances response to chemotherapyMontserrat Estruch, Kristian Reckzeh, Camilla Vittori, et al.
Leukemia|July 28, 2021
Molecular landscape and prognostic impact of FLT3-ITD insertion site in acute myeloid leukemia: RATIFY study resultsFrank G Rücker, Ling Du, Tamara J Luck, et al.
Leukemia|July 27, 2021
Decrease post-transplant relapse using donor-derived expanded NK-cellsStefan O Ciurea, Piyanuch Kongtim, Doris Soebbing, et al.
Leukemia|June 1, 1990
Molecular analysis of a CML patient with a long duration of chronic phase before and after lymphoid blast crisisC M Price, M D Foadi, G J Morgan, et al.
Leukemia|April 24, 2012
Specific small nucleolar RNA expression profiles in acute leukemiaW Valleron, E Laprevotte, E-F Gautier, et al.
Leukemia|April 3, 2013
Oral lenalidomide with rituximab in relapsed or refractory diffuse large cell, follicular and transformed lymphoma: a phase II clinical trialM Wang, N Fowler, N Wagner-Bartak, et al.
Leukemia|April 6, 2013
Distinct patterns of novel gene mutations in poor-prognostic stereotyped subsets of chronic lymphocytic leukemia: the case of SF3B1 and subset #2J C Strefford, L-A Sutton, P Baliakas, et al.
Leukemia|May 22, 2013
Leukemia-initiating cell activity requires calcineurin in T-cell acute lymphoblastic leukemiaS Gachet, E Genescà, D Passaro, et al.
Leukemia|March 15, 2013
Multiple mechanisms deregulate EZH2 and histone H3 lysine 27 epigenetic changes in myeloid malignanciesS N Khan, A M Jankowska, R Mahfouz, et al.
Leukemia|December 12, 2012
AMPK inhibition enhances apoptosis in MLL-rearranged pediatric B-acute lymphoblastic leukemia cellsB Accordi, L Galla, G Milani, et al.
Pageof 963

Showing results (1481-1490 of 9,628) with videos related to

Sort By:
Pageof 963
Leukemia|December 10, 2020
Targeted inhibition of cooperative mutation- and therapy-induced AKT activation in AML effectively enhances response to chemotherapyMontserrat Estruch, Kristian Reckzeh, Camilla Vittori, et al.
Leukemia|July 28, 2021
Molecular landscape and prognostic impact of FLT3-ITD insertion site in acute myeloid leukemia: RATIFY study resultsFrank G Rücker, Ling Du, Tamara J Luck, et al.
Leukemia|July 27, 2021
Decrease post-transplant relapse using donor-derived expanded NK-cellsStefan O Ciurea, Piyanuch Kongtim, Doris Soebbing, et al.
Leukemia|June 1, 1990
Molecular analysis of a CML patient with a long duration of chronic phase before and after lymphoid blast crisisC M Price, M D Foadi, G J Morgan, et al.
Leukemia|April 24, 2012
Specific small nucleolar RNA expression profiles in acute leukemiaW Valleron, E Laprevotte, E-F Gautier, et al.
Leukemia|April 3, 2013
Oral lenalidomide with rituximab in relapsed or refractory diffuse large cell, follicular and transformed lymphoma: a phase II clinical trialM Wang, N Fowler, N Wagner-Bartak, et al.
Leukemia|April 6, 2013
Distinct patterns of novel gene mutations in poor-prognostic stereotyped subsets of chronic lymphocytic leukemia: the case of SF3B1 and subset #2J C Strefford, L-A Sutton, P Baliakas, et al.
Leukemia|May 22, 2013
Leukemia-initiating cell activity requires calcineurin in T-cell acute lymphoblastic leukemiaS Gachet, E Genescà, D Passaro, et al.
Leukemia|March 15, 2013
Multiple mechanisms deregulate EZH2 and histone H3 lysine 27 epigenetic changes in myeloid malignanciesS N Khan, A M Jankowska, R Mahfouz, et al.
Leukemia|December 12, 2012
AMPK inhibition enhances apoptosis in MLL-rearranged pediatric B-acute lymphoblastic leukemia cellsB Accordi, L Galla, G Milani, et al.
Pageof 963